L'Oréal Groupe has increased its stake in Galderma to 20% by acquiring an additional 10%, reinforcing their partnership in the fast-growing aesthetics market.

Information on the Target: Galderma

Galderma, a global leader in dermatology, operates in approximately 90 countries and is known for its innovative, science-based portfolio that includes premium brands and services across the rapidly evolving dermatology market. Established in 1981, Galderma focuses on the comprehensive needs of the skin, offering solutions in Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. The company is committed to advancing dermatological care, ensuring high-quality outcomes for consumers and patients in collaboration with healthcare professionals.

With a strong emphasis on customer satisfaction and advanced dermatological expertise, Galderma has positioned itself as a premier partner for skin health. The company's agility and dedication to meeting individual patient needs have allowed it to thrive in an increasingly competitive market, solidifying its status as a frontrunner in dermatology.

Industry Overview in the Target’s Specific Country

The dermatology market has been experiencing significant growth globally, driven by increasing awareness of skin health and the rising demand for effective skincare treatments. In recent years, there has bee